Content about National Multiple Sclerosis Society

January 10, 2011

Hygenic/Performance Health, makers of Perform and Biofreeze pain relievers, donated Perform pain reliever product samples and coupons in support of the National Multiple Sclerosis Society 2011 Run to Stop MS, MS Walks and MS Bike events.

AKRON, Ohio — Hygenic/Performance Health, makers of Perform and Biofreeze pain relievers, donated Perform pain reliever product samples and coupons in support of the National Multiple Sclerosis Society 2011 Run to Stop MS, MS Walks and MS Bike events.

September 21, 2010

The Food and Drug Administration has approved a drug for reducing relapses in patients with...

SILVER SPRING, Md. The Food and Drug Administration has approved a drug for reducing relapses in patients with multiple sclerosis.

 

The FDA announced Wednesday the approval of Swiss drug maker Novartis’ Gilenia (fingolimod) capsules, saying it was the first oral drug that can slow the progression of disability in patients with MS and offered an alternative to injected drugs.

 

 

Around 400,000 people in the United States and 2.1 million worldwide have MS, according to the National Multiple Sclerosis Society.